Aurora Cannabis (ACB) Other Operating Expenses (2018 - 2025)
Aurora Cannabis (ACB) posted quarterly Other Operating Expenses of -$23.2 million for Q3 2025, down 67380.18% year-on-year from N/an in Q3 2024, and down 67380.18% on a QoQ basis from $34453.5 in Q3 2024.
Aurora Cannabis (ACB) Other Operating Expenses (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Other Operating Expenses for 8 consecutive years, with -$23.2 million the latest figure, recorded in Q3 2025.
- Quarterly Other Operating Expenses fell 67380.18% year-over-year to -$23.2 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$23.2 million (down 993.81% YoY) and the FY2026 annual result came in at $52.6 million, down 3.13% from the prior year.
- Other Operating Expenses fell to -$23.2 million in Q3 2025 per ACB's latest filing, from $34453.5 in the prior quarter.
- Over the last five years, Other Operating Expenses for ACB reached as high as $764.0 million in Q2 2023 and fell as low as -$5.2 billion in Q3 2023.
- A 5-year average of -$546.1 million and a median of -$23.2 million in 2025 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2021 — Other Operating Expenses surged 8371.75% — and 2025, when it slumped 67380.18%.
- Year by year, Other Operating Expenses stood at $25.1 million in 2021, then sank by 1433.93% to -$334.3 million in 2022, then plunged by 1447.95% to -$5.2 billion in 2023, then soared by 100.0% to $34453.5 in 2024, then sank by 67380.18% to -$23.2 million in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$23.2 million, $34453.5, and $2.6 million for Q3 2025, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -23.18 Mn |
| Sep 30, 2024 | 34,453.51 |
| Jun 30, 2024 | 2.56 Mn |
| Sep 30, 2023 | -5.18 Bn |
| Jun 30, 2023 | 764.00 Mn |
| Dec 31, 2022 | -334.31 Mn |
| Sep 30, 2022 | -347.95 Mn |
| Jun 30, 2022 | -358.80 Mn |
| Mar 31, 2022 | -585.59 Mn |
| Dec 31, 2021 | 25.06 Mn |
| Sep 30, 2021 | 25.56 Mn |
| Dec 31, 2020 | -302,986.59 |
| Sep 30, 2020 | -2.54 Mn |
| Jun 30, 2020 | -524.49 Mn |
| Mar 31, 2020 | 36.24 Mn |
| Dec 31, 2019 | 631.93 Mn |
| Sep 30, 2019 | 49.96 Mn |
| Mar 31, 2019 | -6.77 Mn |
| Dec 31, 2018 | 524,272.89 |
| Sep 30, 2018 | 61.62 Mn |